These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33667601)

  • 41. Cholinergic and neurogenic mechanisms in obstructive airways disease.
    Bleecker ER
    Am J Med; 1986 Nov; 81(5A):93-102. PubMed ID: 2878614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Muscarinic signaling in the cochlea: presynaptic and postsynaptic effects on efferent feedback and afferent excitability.
    Maison SF; Liu XP; Vetter DE; Eatock RA; Nathanson NM; Wess J; Liberman MC
    J Neurosci; 2010 May; 30(19):6751-62. PubMed ID: 20463237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Airway structural components drive airway smooth muscle remodeling in asthma.
    Dekkers BG; Maarsingh H; Meurs H; Gosens R
    Proc Am Thorac Soc; 2009 Dec; 6(8):683-92. PubMed ID: 20008876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cultures of airway parasympathetic nerves express functional M2 muscarinic receptors.
    Fryer AD; Elbon CL; Kim AL; Xiao HQ; Levey AI; Jacoby DB
    Am J Respir Cell Mol Biol; 1996 Dec; 15(6):716-25. PubMed ID: 8969265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of insulin in antigen-induced airway eosinophilia and neuronal M2 muscarinic receptor dysfunction.
    Belmonte KE; Fryer AD; Costello RW
    J Appl Physiol (1985); 1998 Nov; 85(5):1708-18. PubMed ID: 9804573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuronal M2 muscarinic receptor function in guinea-pig lungs is inhibited by indomethacin.
    Fryer AD; Okanlami OA
    Am Rev Respir Dis; 1993 Mar; 147(3):559-64. PubMed ID: 8442587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Airway inflammation and autonomic control.
    Barnes PJ
    Eur J Respir Dis Suppl; 1986; 147():80-7. PubMed ID: 2876912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Innervation of the airways in asthma bronchiale and chronic obstructive pulmonary disease (COPD)].
    Dinh QT; Suhling H; Fischer A; Braun A; Welte T
    Pneumologie; 2011 May; 65(5):283-92. PubMed ID: 21271508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Peptidergic and sensory mechanisms, parasympathetic and sympathetic nerves].
    Lundberg JM; Lundblad L; Martling CR; Anggård A
    Lakartidningen; 1984 Dec; 81(52):4939-42. PubMed ID: 6098795
    [No Abstract]   [Full Text] [Related]  

  • 50. New perspectives in bronchial asthma: pathological, immunological alterations, biological targets, and pharmacotherapy.
    Mandlik DS; Mandlik SK
    Immunopharmacol Immunotoxicol; 2020 Dec; 42(6):521-544. PubMed ID: 32938247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticholinergic therapy for airway diseases.
    Jacoby DB; Fryer AD
    Life Sci; 2001 Apr; 68(22-23):2565-72. PubMed ID: 11392627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of inflammatory cells on neuronal M2 muscarinic receptor function in the lung.
    Fryer AD; Adamko DJ; Yost BL; Jacoby DB
    Life Sci; 1999; 64(6-7):449-55. PubMed ID: 10069509
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Control of airway caliber by autonomic nerves in asthma and in chronic obstructive pulmonary disease.
    de Jongste JC; Jongejan RC; Kerrebijn KF
    Am Rev Respir Dis; 1991 Jun; 143(6):1421-6. PubMed ID: 2048831
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD.
    Kistemaker LE; Oenema TA; Meurs H; Gosens R
    Life Sci; 2012 Nov; 91(21-22):1126-33. PubMed ID: 22406302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target.
    Meurs H; Dekkers BG; Maarsingh H; Halayko AJ; Zaagsma J; Gosens R
    Pulm Pharmacol Ther; 2013 Feb; 26(1):145-55. PubMed ID: 22842340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation.
    Baelder R; Fuchs B; Bautsch W; Zwirner J; Köhl J; Hoymann HG; Glaab T; Erpenbeck V; Krug N; Braun A
    J Immunol; 2005 Jan; 174(2):783-9. PubMed ID: 15634899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Airway Vagal Neuroplasticity Associated with Respiratory Viral Infections.
    Zaccone EJ; Undem BJ
    Lung; 2016 Feb; 194(1):25-9. PubMed ID: 26678280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Airway autonomic nervous system dysfunction and asthma].
    Ichinose M
    Nihon Yakurigaku Zasshi; 1998 Apr; 111(4):195-203. PubMed ID: 9618704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Sensory-nerves and airway inflammation: interaction with beta-2-adrenoceptor agonists].
    Advenier C; Faisy C; Naline E; Planquette B; Devillier P
    Ann Pharm Fr; 2007 Jul; 65(4):220-7. PubMed ID: 17652989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neural control of airway vasculature and edema.
    Widdicombe JG
    Am Rev Respir Dis; 1991 Mar; 143(3 Pt 2):S18-21. PubMed ID: 2003685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.